Company Filing History:
2 out of 202 
1 out of 523 
1 out of 832,891 Years Active: 1999-2007
Title: W Jeffrey Howe: Innovator in Recombinant Human BACE Polypeptides
Introduction
W Jeffrey Howe is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant human BACE polypeptides. With a total of 4 patents to his name, Howe's work has implications for medical research and therapeutic applications.
Latest Patents
One of Howe's latest patents is focused on Modified BACE. This invention relates to recombinant human BACE polypeptides that possess a modified amino acid sequence at position 33 of the BACE sequence. The patent also covers polynucleotides, expression vectors, host cells, and methods for producing these modified recombinant human BACE polypeptides. This innovation showcases Howe's commitment to advancing biotechnological solutions.
Career Highlights
Throughout his career, W Jeffrey Howe has worked with various organizations, including Elan Pharmaceuticals, Inc. His experience in the pharmaceutical industry has allowed him to apply his innovative ideas in practical settings, contributing to advancements in medical science.
Collaborations
Howe has collaborated with several professionals in his field, including Linda Louise Maggiora and Suvit Thaisrivongs. These collaborations have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
W Jeffrey Howe's contributions to the field of biotechnology, particularly through his patents on recombinant human BACE polypeptides, highlight his role as a significant inventor. His work continues to influence advancements in medical research and therapeutic applications.